{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:22:45Z","timestamp":1777015365673,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.drugalcdep.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T12:46:10Z","timestamp":1500468370000},"page":"315-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014"],"prefix":"10.1016","volume":"177","author":[{"given":"Qi","family":"Guan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Khuu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheryl","family":"Spithoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Kiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meldon","family":"Kahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Tadrous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Leece","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0005","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1080\/10826080802483936","article-title":"Supervised methadone consumption: client issues and stigma","volume":"44","author":"Anstice","year":"2009","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1055\/s-0032-1330033","article-title":"Safety, effectiveness and tolerance of buprenorphine-naloxone in the treatment of opioid dependence: results from a nationwide non-interventional study in routine care","volume":"46","author":"Apelt","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1940-0640-9-19","article-title":"Review of the assessment and management of neonatal abstinence syndrome","volume":"9","author":"Bagley","year":"2014","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0020","series-title":"Primary Care and Methadone Patients in Treatment for Five Years or More: The Patient and Physician Perspective","author":"Bartoszko","year":"2012"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0025","doi-asserted-by":"crossref","first-page":"639","DOI":"10.18553\/jmcp.2014.20.6.639","article-title":"Exploration of claims-based utilization measures for detecting potential nonmedical use of prescription drugs","volume":"20","author":"Birt","year":"2014","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/IJGM.S53170","article-title":"Management of opioid addiction with buprenorphine: french history and current management","author":"Bourkaib","year":"2014","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1300\/J069v22n03_03","article-title":"Impact of methadone program philosophy changes on early treatment outcomes","volume":"22","author":"Brands","year":"2003","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","article-title":"Psychiatric and substance use comorbidity among treatment-seeking opioid abusers","volume":"54","author":"Brooner","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0045","series-title":"Supply, Distribution and Migration of Physicians in Canada, 2015: Methadological Notes","author":"Canadian Institute for Health Information","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/508184","article-title":"Buprenorphine use: the international experince","volume":"43","author":"Carrieri","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0055","series-title":"Methadone Maintenance Treatment Client Handbook","author":"Centre for Addiction and Mental Health","year":"2008"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/753409","article-title":"Evaluation of a low-threshold\/high-tolerance methadone maintenance treatment clinic in Saint John, New Brunswick, Canada : One year retention rate and illicit drug use","volume":"2013","author":"Christie","year":"2013","journal-title":"J. Addict."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0070","series-title":"Fee Cuts Pushing Ontario Doctors to Close Methadone Clinics","author":"Church","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0075","series-title":"Funding for Methadone Maintenance Treatment","author":"Cressy","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0080","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.addbeh.2011.01.004","article-title":"Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness","volume":"36","author":"Deering","year":"2011","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0085","first-page":"e92","article-title":"Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario","volume":"57","author":"Dhalla","year":"2011","journal-title":"Can. Fam. Physician Med. Fam. Can."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0090","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.2307\/1939238","article-title":"Bootstrapping the gini coefficient of inequality","volume":"68","author":"Dixon","year":"1987","journal-title":"Ecology"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0095","first-page":"37","article-title":"Update on the clinical use of buprenorphine: in opioid-related disorders","volume":"58","author":"Ducharme","year":"2012","journal-title":"Can. Fam. Physician M\u00e9decin Fam. Can."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0100","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jama.2016.9795","article-title":"Clinical management of opioid use disorder","volume":"316","author":"Dunlap","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0105","first-page":"15","article-title":"Mental health service use by recent immigrants from different world regions and by non-immigrants in Ontario, Canada : a cross-sectional study","author":"Durbin","year":"2015","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0110","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/ADM.0000000000000156","article-title":"Evaluating the effectiveness of first-time methadone maintenance therapy across northern, rural, and urban regions of Ontario, Canada","volume":"9","author":"Eibl","year":"2015","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11920-007-0046-2","article-title":"Why buprenorphine is so successful in treating opiate addiction in France","volume":"9","author":"Fatseas","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0120","doi-asserted-by":"crossref","DOI":"10.1186\/s13011-016-0055-4","article-title":"Treatment of prescription opioid disorders in Canada : looking at the other epidemic?","volume":"11","author":"Fischer","year":"2016","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0125","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0130","first-page":"1407","article-title":"The assessment of inequality in the geographical distribution of burn beds in Iran","volume":"7","author":"Geravandi","year":"2015","journal-title":"Electron. Phys."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0740-5472(03)00066-7","article-title":"Urine testing in methadone maintenance treatment: applications and limitations","volume":"25","author":"Goldstein","year":"2003","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0140","first-page":"281","article-title":"Buprenorphine for opiate dependence: clinic based therapy in Israel","volume":"51","author":"Goren","year":"2014","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0145","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.jenvman.2009.01.003","article-title":"Lorenz Curve and Gini Coefficient: novel tools for analysing seasonal variation of environmental radon gas","volume":"90","author":"Groves-Kirkby","year":"2009","journal-title":"J. Environ. Manage."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0150","series-title":"Buprenorphine\/Naloxone for Opioid Dependence","author":"Handford","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0155","series-title":"Report of the Methadone Maintenance Treatment Practices Task Force","author":"Hart","year":"2007"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1300\/J465v28n02_02","article-title":"Women and opioid dependence treatment: office-based versus opioid treatment program-based care?","volume":"28","author":"Jones","year":"2007","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/10826084.2010.509854","article-title":"Quality of life profiles and changes in the course of maintenance treatment among 1,015 patients with severe opioid dependence","volume":"46","author":"Karow","year":"2011","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0170","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.drugalcdep.2003.11.014","article-title":"Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program","volume":"74","author":"Kidorf","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1370\/afm.1664","article-title":"Effect of payment incentives on cancer screening in Ontario primary care","volume":"12","author":"Kiran","year":"2014","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0180","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care\u2013based models for the treatment of opioid use disorder: a scoping review","volume":"166","author":"Korthuis","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0185","first-page":"67","article-title":"Coding accuracy of administrative drug claims in the Ontario Drug Benefit database","volume":"10","author":"Levy","year":"2003","journal-title":"Can. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0190","doi-asserted-by":"crossref","first-page":"e0123687","DOI":"10.1371\/journal.pone.0123687","article-title":"Factors associated with methadone treatment duration: a Cox Regression analysis","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0195","series-title":"National Clinical Guidelines and Procedures for the Use of Buprenorphine in the Treatment of Opioid Dependence","author":"Lintzeris","year":"2006"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0200","article-title":"A cross-Canada scan of methadone maintenance treatment policy developments","author":"Luce","year":"2011","journal-title":"Ott. Can. Exec. Counc. Addict."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0205","first-page":"137","article-title":"Evaluation of 6 remote first nations community-based buprenorphine programs in northwestern Ontario: retrospective study","volume":"63","author":"Mamakwa","year":"2017","journal-title":"Can. Fam. Phys. Med. Fam. Can."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0210","series-title":"Cochrane Database of Systematic Reviews","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2003"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0215","series-title":"Cochrane Database of Systematic Reviews","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0220","series-title":"Cochrane Database of Systematic Reviews","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0225","doi-asserted-by":"crossref","first-page":"b2803","DOI":"10.1136\/bmj.b2803","article-title":"We need minimally disruptive medicine","volume":"339","author":"May","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0230","series-title":"Methadone Treatment and Services Advisory Committee: Final Report","author":"Methadone Advisory Committee","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0235","series-title":"Ontario Drug Benefit Formulary\/Comparative Drug Index: Summary of Changes","author":"Ministry of Health and Long-Term Care","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0240","series-title":"Strategy to Prevent Opioid Addiction and Overdose","author":"Ministry of Health and Long-Term Care","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0245","series-title":"Methadone and Buprenorphine for the Management of Opioid Dependence","author":"National Institute for Health and Care Excellence","year":"2007"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0250","series-title":"Cochrane Database of Systematic Reviews","article-title":"Opioid agonist treatment for pharmaceutical opioid dependent people","author":"Nielsen","year":"2016"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0255","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.2017.0076","article-title":"Addressing physician burnout: the way forward","volume":"317","author":"Shanafelt","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0260","first-page":"200","article-title":"Primary care management of opioid use disorders: abstinence, methadone, or buprenorphine-naloxone?","volume":"63","author":"Srivastava","year":"2017","journal-title":"Can. Fam. Phys. Med. Fam. Can."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0265","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/15389588.2012.689451","article-title":"Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration","volume":"14","author":"Strand","year":"2013","journal-title":"Traffic Inj. Prev."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0270","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.addbeh.2004.09.004","article-title":"Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence","volume":"30","author":"Strike","year":"2005","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0275","series-title":"Federal Guidelines for Opioid Treatment Programs (No. (SMA) PEP 15-FEDGUIDEOTP)","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0280","series-title":"Methadone Maintenance Treatment: Program Standards and Clinical Guidelines","author":"The College of Physicians and Surgeons of Ontario","year":"2011"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0285","first-page":"330","article-title":"Socioeconomic datas, the course of pregnancy and delivery in opioid-addicted women and women under substitution therapy","volume":"72","author":"Vavrinkov\u00e1","year":"2007","journal-title":"Cesk\u00e1 Gynekol. Cesk\u00e1 L\u00e9karsk\u00e1 Spolecnost J Ev Purkyne"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0290","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cpr.2009.10.006","article-title":"A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction","volume":"30","author":"Veilleux","year":"2010","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0295","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0740-5472(01)00189-1","article-title":"Practice-based buprenorphine maintenance treatment (BMT): how do French healthcare providers manage the opiate-addicted patients?","volume":"21","author":"Vignau","year":"2001","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0300","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.drugalcdep.2005.11.020","article-title":"Predictors of retention in methadone programs: a signal detection analysis","volume":"83","author":"Villafranca","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0305","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1001\/jama.283.10.1343","article-title":"Provision of methadone treatment in primary care medical practices: review of the Scottish experience and implications for US policy","volume":"283","author":"Weinrich","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2017.05.002_bib0310","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2012.07.001","article-title":"Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009","volume":"127","author":"Welle-Strand","year":"2013","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617302570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871617302570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T04:58:08Z","timestamp":1659243488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871617302570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":62,"alternative-id":["S0376871617302570"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.05.002","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}